Fatty acids are traditionally obtained by extracting oils from plant, fish, or animal tissues, however, the composition in these sources generally depends on the season and location. There is a requirement to find alternative sources to meet the growing demand across the food, pharmaceuticals and cosmetic industries.

A feasibility study which offers the potential to improve the production of therapeutic proteins through the development of a purification platform which includes an affinity chromatography step that has been specifically designed for use with a novel set of protein tags.

Scottish biotechnology company ScotBio has developed an environmentally-friendly way of boosting the production and stability of the natural blue pigment phycocyanin, opening the door to access new global markets.

As ENOUGH (formerly 3fBio) move mycoprotein production from their scale up facility in Glasgow to full scale production in the Netherlands, they wanted to design a suite of early diagnosis tests to determine when a batch of product is growing sub-optimally in the hope that issues can be mitigated and avoid reductions in the amount or quality of product.

ŌGI Bio Ltd wanted to explore the feasibility of utilising the University of Edinburgh’s state of the art in-line dilution technology to extend the valid range of OD measurements for their microbioreactors.

Owners of food waste AD plants are looking for alternative ways to valorise waste that contains both plastic and biobased substances. Carbogenics wanted to investigate whether fermentation from screening waste was possible and test a scaled-up version of their process for making biomethane from waste using bacteria.

Using bacteria to clean waste water and recover metal ions.

Turning low value fish waste into high value molecules using biotechnology.

Revive Eco develop green technologies to produce high value products from waste. Their initial focus is on waste coffee grounds from which they extract several high value chemicals and consumer products.

This Feasibility project sought to obtain data on whether and how the CellMaker aids the growth of mammalian cells for use in the production of medicines, therapeutics and research reagents.

Waste root vegetables could help stop microbes growing on medical implants.

Funding of just under £50k from IBioIC enabled Ingenza to gain invaluable expertise and enhanced their ability to access new markets and end users thanks to the technology developed as a result of this project.

This project investigated the feasibility of using oils extracted from fish industry waste to produce ingredients such as detergents and foaming agents for use in industrial products.

Improving the process for making sustainable meat alternatives at scale.

Trialling techniques to assess the chemical properties of chitosan extracted through a novel process.

IBioIC project funding enabled The Antibody Company to develop a novel test that has the potential to substantially reduce spoilage issues for microbrewers.

Using organic waste as a nutrient source to grow fungal mycelium for use as insulation blocks for the construction industry.

Feasibility study helped to support the finance and sign off a £2.2 million capital project, resulting in a new AD plant being in place, commissioned and operational by June 2022.

New collaboration demonstrates environmentally friendly route to precious metal recovery from electronic waste.

A new predictive model for more efficient production of proteins as pharmaceuticals, industrial biocatalysts or numerous other engineering biology applications.